Web Analytics

Investor Profile

Johnson & Johnson

Johnson & Johnson United States - New Brunswick, NJ
INVESTOR

1 Disclosed Funding Rounds $25,000,000
28 Participating Investments




Profound Change Requires Boldness. Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have

Invested In

Company Date Round Raised
  Causaly July, 14 ,2023 Series B $60,000,000
  MedCrypt November, 02 ,2022 Series B $25,000,000
  Arialys Therapeutics, Inc. September, 13 ,2023 Seed $58,000,000
  Moon Surgical June, 30 ,2022 Series A $31,300,000
  SwipeRx May, 23 ,2022 Series B $27,000,000
  Osteal Therapeutics September, 26 ,2023 Series C $23,000,000
  Rapport Therapeutics March, 08 ,2023 Series A $100,000,000
  RefleXion Medical November, 17 ,2023 Unknown $105,000,000
  ArteraAI March, 27 ,2023 Unknown $90,000,000
  Health In Her HUE January, 09 ,2024 Unknown $3,000,000
  Solenic Medical June, 21 ,2023 Series A $5,100,000
  FogPharma March, 05 ,2024 Series E $145,000,000
  Causaly July, 14 ,2023 Series B $60,000,000
  Tempo Therapeutics March, 21 ,2024 Series A $12,000,000
  Arialys Therapeutics, Inc. September, 13 ,2023 Seed $58,000,000
  HistoSonics, Inc. August, 16 ,2024 Series D $102,000,000
  Osteal Therapeutics September, 26 ,2023 Series C $23,000,000
  SpectraWAVE, Inc. September, 12 ,2024 Series B $50,000,000
  RefleXion Medical November, 17 ,2023 Unknown $105,000,000
  ONL Therapeutics September, 17 ,2024 Series D $65,000,000
  Health In Her HUE January, 09 ,2024 Unknown $3,000,000
  TRexBio November, 14 ,2024 Series B $84,000,000
  FogPharma March, 05 ,2024 Series E $145,000,000
  Tempo Therapeutics March, 21 ,2024 Series A $12,000,000
  HistoSonics, Inc. August, 16 ,2024 Series D $102,000,000
  SpectraWAVE, Inc. September, 12 ,2024 Series B $50,000,000
  ONL Therapeutics September, 17 ,2024 Series D $65,000,000
  TRexBio November, 14 ,2024 Series B $84,000,000